SOURCE: Axxess Pharma, Inc.

Axxess Pharma, Inc.

February 04, 2014 08:00 ET

AllStar Health Brands Inc., a Subsidiary of AXXE, Announces Purchase Order (PO) for 25,000 Units of New TapouT Extreme Muscle and TapouT Muscle Recovery Supplements

TORONTO, ON--(Marketwired - Feb 4, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce Private Label Nutraceuticals, a Premium manufacturer of nutritional supplements, based in Norcross, Georgia has placed an initial purchase order for 25,000 units of Axxess Pharmas newest product offerings: TapouT Extreme Muscle Growth and TapouT Muscle Recovery. The purchase order is through Axxess Pharmas wholly-owned subsidiary, AllStar Health Brands Inc.

Kevin Harden, Vice-President of Sales for Private Label Nutraceuticals, stated: "As an industry leading contract manufacturer of high-quality supplements, we are truly excited to work with a primary distributor in the sport nutrition realm. Because of TapouT's unwavering dedication to superior, innovative product, as well as extensive experience in the e-commerce arena, we are honored to have been chosen as their primary contract manufacturer, and look forward to supporting the growth of their supplement business. Kevin further stated: "We are thrilled to start manufacturing these two powerful, natural, muscle growth and recovery supplements under the TapouT brand. We have worked with Axxess to develop the optimal formula for performance and recovery, and expect these products to do extremely well."

Daniel Bagi, M.D. President of Axxess, further stated, "We believe these new products offer the best ingredients for athletes and the lay person who works out regularly to maximize their workout regimens and also recover quickly enough to keep their workout schedules intact. AllStar anticipates this first order to sell out Q1 2014, adding close to $1 million in revenues. "

AllStar expects to launch these new products later this month, through both online and retail channels.

About Private Label Nutraceuticals:
Private Label Nutraceuticals is an industry leader in supplement manufacturing, assisting our clients in each step of developing their brand, from concept to distribution. Tracking the latest industry trends allows us to offer an extensive list of stock products, available either as our in-house brand or labeled with your brand. Private Label Nutraceuticals can also formulate custom products to meet the specific needs of our clients. Our comprehensive services also include custom formulation development, quality control testing, graphic design support, packaging procurement and label creation, marketing support, and both domestic and international fulfillment services. For more info, please call, email, or visit us at http://www.PrivateLabelNutra.com.

About Axxess Pharma Inc.:

Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, to optimal health management through improved nutritional supplements.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.

Safe Harbor Statement

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

Contact Information